Trending Similar Videos
Drug pricing initiatives during the Trump presidency
Tom Bulleit, Ropes & Gray health care partner, discusses the Trump Administration’s latest drug pricing initiatives.
Matt Rizzolo, Ropes & Gray IP litigation partner, discusses the rise and impact of litigation finance, a rapidly growing third-party litigation funding model.
Active nontransparent ETFs
Brian McCabe, Ropes & Gray asset management partner, discusses active nontransparent ETFs and the opportunities they offer to investors and asset managers of traditional mutual funds.
False Claims Act: three years after Escobar
Kirsten Mayer, Ropes & Gray litigation partner, provides an update on the False Claims Act (FCA), three years after the Supreme Court’s decision on Universal Health Services v. U.S. ex rel. Escobar.
DOJ enforcement update: electronic health records
Joshua Levy, co-chair of Ropes & Gray’s litigation & enforcement practice, provides an update on the enforcement of electronic health records by the Department of Justice (DOJ).
Section 101: confusion over patentable subject matter
Matt Rizzolo, Ropes & Gray IP litigation partner, addresses the ongoing confusion over what constitutes patentable subject matter under Section 101 of the Patent Act.